6I3S
Crystal structure of MDM2 in complex with compound 13.
Summary for 6I3S
Entry DOI | 10.2210/pdb6i3s/pdb |
Descriptor | E3 ubiquitin-protein ligase Mdm2, (3~{S},3'~{R},3'~{a}~{S},6'~{a}~{R})-6-chloranyl-3'-(3-chloranyl-2-fluoranyl-phenyl)-1'-(cyclopropylmethyl)spiro[1~{H}-indole-3,2'-3~{a},6~{a}-dihydro-3~{H}-pyrrolo[3,4-b]pyrrole]-2,4'-dione, GLYCEROL, ... (5 entities in total) |
Functional Keywords | inhibitor, ligase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 11754.45 |
Authors | Bader, G.,Kessler, D. (deposition date: 2018-11-07, release date: 2018-12-19, Last modification date: 2024-05-15) |
Primary citation | Gollner, A.,Weinstabl, H.,Fuchs, J.E.,Rudolph, D.,Garavel, G.,Hofbauer, K.S.,Karolyi-Oezguer, J.,Gmaschitz, G.,Hela, W.,Kerres, N.,Grondal, E.,Werni, P.,Ramharter, J.,Broeker, J.,McConnell, D.B. Targeted Synthesis of Complex Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2-p53 Inhibitors. ChemMedChem, 14:88-93, 2019 Cited by PubMed: 30458062DOI: 10.1002/cmdc.201800617 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.77 Å) |
Structure validation
Download full validation report